A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.

A research team at the Medical University of Vienna led by Maria Sibilia has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone ...

Researchers believe the innovative idea holds immense promise for tackling a wide range of diseases including cancer through ...

Researchers at MedUni Vienna have developed a combination therapy using systemic interferon-I and topical imiquimod.

As noted above, stellate cell activation is the central event in hepatic fibrosis. Activation consists of 2 major phases: (1) initiation (also called apreinflammatory stage) and (2) perpetuation ...

T-cell receptors in the hearts of patients with ... researchers found an increased number of cytotoxic T cells, conventional dendritic cells and fibroblasts. “When you have heart inflammation ...

A breakthrough study published today in the Journal of Neuroscience sheds new light on how brain cells relay critical ... mechanism involving the activation of receptors and ion channels ...

Innate immunity is an immunological subsystem that comprises the cells and mechanisms ... molecule bridging Toll-like receptor signalling and transcription activation by IRF5.

eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that ...